Cargando…
High and Rapid Increase in Seroprevalence for SARS-CoV-2 in Conakry, Guinea: Results From 3 Successive Cross-Sectional Surveys (ANRS COV16-ARIACOV)
We conducted 3 successive seroprevalence surveys, 3 months apart, using multistage cluster sampling to measure the extent and dynamics of the severe acute respiratory syndrome coronavirus 2 epidemic in Conakry, the capital city of Guinea. Seroprevalence increased from 17.3% (95% CI, 12.4%–23.8%) in...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992319/ https://www.ncbi.nlm.nih.gov/pubmed/35493112 http://dx.doi.org/10.1093/ofid/ofac152 |
_version_ | 1784683708680241152 |
---|---|
author | Soumah, Abou Aissata Diallo, Mamadou Saliou Kalifa Guichet, Emilande Maman, David Thaurignac, Guillaume Keita, Alpha Kabinet Bouillin, Julie Diallo, Haby Pelloquin, Raphael Ayouba, Ahidjo Kpamou, Cece Peeters, Martine Delaporte, Eric Etard, Jean-Francois Toure, Abdoulaye |
author_facet | Soumah, Abou Aissata Diallo, Mamadou Saliou Kalifa Guichet, Emilande Maman, David Thaurignac, Guillaume Keita, Alpha Kabinet Bouillin, Julie Diallo, Haby Pelloquin, Raphael Ayouba, Ahidjo Kpamou, Cece Peeters, Martine Delaporte, Eric Etard, Jean-Francois Toure, Abdoulaye |
author_sort | Soumah, Abou Aissata |
collection | PubMed |
description | We conducted 3 successive seroprevalence surveys, 3 months apart, using multistage cluster sampling to measure the extent and dynamics of the severe acute respiratory syndrome coronavirus 2 epidemic in Conakry, the capital city of Guinea. Seroprevalence increased from 17.3% (95% CI, 12.4%–23.8%) in December 2020 during the first survey (S1) to 28.9% (95% CI, 25.6%–32.4%) in March/April 2021 (S2), then to 42.4% (95% CI, 39.5%–45.3%) in June 2021 (S3). This significant overall trend of increasing seroprevalence (P < .0001) was also significant in every age class, illustrating a sustained transmission within the whole community. These data may contribute to defining cost-effective response strategies. |
format | Online Article Text |
id | pubmed-8992319 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-89923192022-04-12 High and Rapid Increase in Seroprevalence for SARS-CoV-2 in Conakry, Guinea: Results From 3 Successive Cross-Sectional Surveys (ANRS COV16-ARIACOV) Soumah, Abou Aissata Diallo, Mamadou Saliou Kalifa Guichet, Emilande Maman, David Thaurignac, Guillaume Keita, Alpha Kabinet Bouillin, Julie Diallo, Haby Pelloquin, Raphael Ayouba, Ahidjo Kpamou, Cece Peeters, Martine Delaporte, Eric Etard, Jean-Francois Toure, Abdoulaye Open Forum Infect Dis Major Article We conducted 3 successive seroprevalence surveys, 3 months apart, using multistage cluster sampling to measure the extent and dynamics of the severe acute respiratory syndrome coronavirus 2 epidemic in Conakry, the capital city of Guinea. Seroprevalence increased from 17.3% (95% CI, 12.4%–23.8%) in December 2020 during the first survey (S1) to 28.9% (95% CI, 25.6%–32.4%) in March/April 2021 (S2), then to 42.4% (95% CI, 39.5%–45.3%) in June 2021 (S3). This significant overall trend of increasing seroprevalence (P < .0001) was also significant in every age class, illustrating a sustained transmission within the whole community. These data may contribute to defining cost-effective response strategies. Oxford University Press 2022-03-23 /pmc/articles/PMC8992319/ /pubmed/35493112 http://dx.doi.org/10.1093/ofid/ofac152 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Major Article Soumah, Abou Aissata Diallo, Mamadou Saliou Kalifa Guichet, Emilande Maman, David Thaurignac, Guillaume Keita, Alpha Kabinet Bouillin, Julie Diallo, Haby Pelloquin, Raphael Ayouba, Ahidjo Kpamou, Cece Peeters, Martine Delaporte, Eric Etard, Jean-Francois Toure, Abdoulaye High and Rapid Increase in Seroprevalence for SARS-CoV-2 in Conakry, Guinea: Results From 3 Successive Cross-Sectional Surveys (ANRS COV16-ARIACOV) |
title | High and Rapid Increase in Seroprevalence for SARS-CoV-2 in Conakry, Guinea: Results From 3 Successive Cross-Sectional Surveys (ANRS COV16-ARIACOV) |
title_full | High and Rapid Increase in Seroprevalence for SARS-CoV-2 in Conakry, Guinea: Results From 3 Successive Cross-Sectional Surveys (ANRS COV16-ARIACOV) |
title_fullStr | High and Rapid Increase in Seroprevalence for SARS-CoV-2 in Conakry, Guinea: Results From 3 Successive Cross-Sectional Surveys (ANRS COV16-ARIACOV) |
title_full_unstemmed | High and Rapid Increase in Seroprevalence for SARS-CoV-2 in Conakry, Guinea: Results From 3 Successive Cross-Sectional Surveys (ANRS COV16-ARIACOV) |
title_short | High and Rapid Increase in Seroprevalence for SARS-CoV-2 in Conakry, Guinea: Results From 3 Successive Cross-Sectional Surveys (ANRS COV16-ARIACOV) |
title_sort | high and rapid increase in seroprevalence for sars-cov-2 in conakry, guinea: results from 3 successive cross-sectional surveys (anrs cov16-ariacov) |
topic | Major Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992319/ https://www.ncbi.nlm.nih.gov/pubmed/35493112 http://dx.doi.org/10.1093/ofid/ofac152 |
work_keys_str_mv | AT soumahabouaissata highandrapidincreaseinseroprevalenceforsarscov2inconakryguinearesultsfrom3successivecrosssectionalsurveysanrscov16ariacov AT diallomamadousalioukalifa highandrapidincreaseinseroprevalenceforsarscov2inconakryguinearesultsfrom3successivecrosssectionalsurveysanrscov16ariacov AT guichetemilande highandrapidincreaseinseroprevalenceforsarscov2inconakryguinearesultsfrom3successivecrosssectionalsurveysanrscov16ariacov AT mamandavid highandrapidincreaseinseroprevalenceforsarscov2inconakryguinearesultsfrom3successivecrosssectionalsurveysanrscov16ariacov AT thaurignacguillaume highandrapidincreaseinseroprevalenceforsarscov2inconakryguinearesultsfrom3successivecrosssectionalsurveysanrscov16ariacov AT keitaalphakabinet highandrapidincreaseinseroprevalenceforsarscov2inconakryguinearesultsfrom3successivecrosssectionalsurveysanrscov16ariacov AT bouillinjulie highandrapidincreaseinseroprevalenceforsarscov2inconakryguinearesultsfrom3successivecrosssectionalsurveysanrscov16ariacov AT diallohaby highandrapidincreaseinseroprevalenceforsarscov2inconakryguinearesultsfrom3successivecrosssectionalsurveysanrscov16ariacov AT pelloquinraphael highandrapidincreaseinseroprevalenceforsarscov2inconakryguinearesultsfrom3successivecrosssectionalsurveysanrscov16ariacov AT ayoubaahidjo highandrapidincreaseinseroprevalenceforsarscov2inconakryguinearesultsfrom3successivecrosssectionalsurveysanrscov16ariacov AT kpamoucece highandrapidincreaseinseroprevalenceforsarscov2inconakryguinearesultsfrom3successivecrosssectionalsurveysanrscov16ariacov AT peetersmartine highandrapidincreaseinseroprevalenceforsarscov2inconakryguinearesultsfrom3successivecrosssectionalsurveysanrscov16ariacov AT delaporteeric highandrapidincreaseinseroprevalenceforsarscov2inconakryguinearesultsfrom3successivecrosssectionalsurveysanrscov16ariacov AT etardjeanfrancois highandrapidincreaseinseroprevalenceforsarscov2inconakryguinearesultsfrom3successivecrosssectionalsurveysanrscov16ariacov AT toureabdoulaye highandrapidincreaseinseroprevalenceforsarscov2inconakryguinearesultsfrom3successivecrosssectionalsurveysanrscov16ariacov |